Archive

Message de service : ce billet est le dernier numero d’Onco Actu redige par son createur

Message de service : ce billet est le dernier numero d’Onco Actu redige par son createur

Fideles lecteurs, sachez que je pars a la retraite fier d’avoir contribue, durant toutes ces annees, a la lutte contre les cancers en France. Gerard Chevalier

Why the ban on nicotine vape fluid will do more harm than good [The Conversation] Last week the federal government’s Office of Drug Control announced changes to the importation of nicotine-containing electronic cigarette fluids that will seriously affect the estimated 227,000 regular e-cigarette users in Australia.

FDA Approves Breast Cancer Treatment That Can Be Administered At Home By Health Care Professional [FDA] Today, the U

Yale Cancer Center Study Validates Combination Therapy for Aggressive Endometrial Cancer [Yale] Yale Cancer Center (YCC) scientists have found that combining the targeted drug trastuzumab with chemotherapy significantly improves survival rates for women with a rare, aggressive form of endometrial cancer. These results may help to change the standard of care worldwide for the disease. The findings are published today in the journal Clinical Cancer Research.

FDA Approves First-Line Immunotherapy for Patients with MSI-H/dMMR Metastatic Colorectal Cancer http://datingranking.net/fr/swipe-review/ [FDA] The FDA’s approval for this indication was based on the results of one multicenter, international, open-label, active-controlled, randomized trial that compared Keytruda with chemotherapy treatment in 307 patients with MSI-H or dMMR metastatic colorectal cancer. Continue reading “Message de service : ce billet est le dernier numero d’Onco Actu redige par son createur”